
The pharmaceutical industry is expected to grow steadily amid strong demand and government support. Therefore, fundamentally strong pharma stocks Novo Nordisk A/S (NVO), Novartis AG (NVS), and AbbVie Inc. (ABBV) could be wise additions to your portfolio now.
According to U.S. pharmaceutical industry statistics, the U.S. will have a 43.72% market share in the global pharma industry in 2023. Also, the U.S. is expected to spend $605 to 635 billion on medicine by 2025.